Breast Cancer
A Phase 1b/2, Open-Label Umbrella Study to Evaluate Safety and Efficacy of Elacestrant in Various Combinations in Patients with Metastatic Breast Cancer (ELEVATE) (STML-ELA-0222)
- Details
ClinicalTrials.gov ID:
NCT05563220
Diagnosis Type:
NA
USOR Number:
- Address
,
P: